Genor Biopharma Holdings Limited (FRA:67N0)
Germany
· Delayed Price · Currency is EUR 0.378
+0.022 (6.18%)
At close: Nov 26, 2025
Genor Biopharma Holdings Market Cap
Genor Biopharma Holdings has a market cap or net worth of €217.29 million as of December 5, 2025. Its market cap has increased by 109.92% in one year.
Market Cap
217.29M
Enterprise Value
95.19M
Revenue
26.63M
Ranking
n/a
PE Ratio
63.22
Stock Price
€0.38
Market Cap Chart
Since October 7, 2020, Genor Biopharma Holdings's market cap has decreased from 1.47B to 217.29M, a decrease of -85.26%. That is a compound annual growth rate of -30.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 217.29M | 95.53% |
| Dec 31, 2024 | 111.13M | 60.08% |
| Dec 29, 2023 | 69.42M | -56.42% |
| Dec 30, 2022 | 159.30M | -60.24% |
| Dec 31, 2021 | 400.69M | -61.30% |
| Dec 31, 2020 | 1.04B | -29.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.46B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |